United States · FDA National Drug Code directory
Ondansetron
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-0132_aba5e1a7-a00a-4e76-b0e3-dfbe4179eec0
- Product NDC
- 71335-0132
- Form
- TABLET, FILM COATED
- Composition / generic term
- Ondansetron
- Labeler
- Bryant Ranch Prepack
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20070727
- Source listing expiry
- 20261231
Source-listed ingredients
- ONDANSETRON HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, FILM COATED in 1 BOTTLE (71335-0132-0) · 71335-0132-0
- 10 TABLET, FILM COATED in 1 BOTTLE (71335-0132-1) · 71335-0132-1
- 3 TABLET, FILM COATED in 1 BOTTLE (71335-0132-2) · 71335-0132-2
- 30 TABLET, FILM COATED in 1 BOTTLE (71335-0132-3) · 71335-0132-3
- 15 TABLET, FILM COATED in 1 BOTTLE (71335-0132-4) · 71335-0132-4
- 6 TABLET, FILM COATED in 1 BOTTLE (71335-0132-5) · 71335-0132-5
- 4 TABLET, FILM COATED in 1 BOTTLE (71335-0132-6) · 71335-0132-6
- 90 TABLET, FILM COATED in 1 BOTTLE (71335-0132-7) · 71335-0132-7
- 12 TABLET, FILM COATED in 1 BOTTLE (71335-0132-8) · 71335-0132-8
- 20 TABLET, FILM COATED in 1 BOTTLE (71335-0132-9) · 71335-0132-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →